Tag: pancreatic ductal adenocarcinoma research

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest malignancies worldwide, notorious for its aggressive nature and dismal survival rates. ...

A groundbreaking new study known as TORPEDO is currently redefining the therapeutic landscape for patients diagnosed with inoperable, non-metastasized pancreatic ...

In a groundbreaking development poised to redefine the treatment landscape for locally advanced pancreatic cancer (LAPC), a new clinical trial ...

In a groundbreaking advance that could revolutionize the treatment of pancreatic cancer, researchers have unveiled a precision laser technique that ...

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most formidable challenges in oncology today, with a dismal five-year survival rate ...

In a groundbreaking study published in Nature, researchers have unraveled a crucial cellular dialogue that sustains pancreatic ductal adenocarcinoma (PDAC), ...

Pancreatic cancer stands as one of the most formidable adversaries in modern oncology, with a notoriously poor prognosis largely due ...

In a groundbreaking advance that promises to reshape the landscape of pancreatic cancer diagnostics, researchers have unveiled innovative 4D-printed microdevices ...

In a groundbreaking advancement bridging oncology and artificial intelligence, researchers have unveiled a cutting-edge machine learning model capable of predicting ...

In the relentless quest to unravel the molecular underpinnings of pancreatic ductal adenocarcinoma (PDAC), a lethal and notoriously aggressive cancer, ...